Announcement by ARYZTA AG

Announcement by ARYZTA AG

ID: 352808

(Thomson Reuters ONE) -
ARYZTA AG /
Announcement by ARYZTA AG
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.

Announcement by ARYZTA AG regarding the pricing of ?250 million Perpetual
Callable Subordinated Securities ('Hybrid Securities') to be issued by its Irish
incorporated financing vehicle, ARYZTA Euro Finance Limited and unconditionally
and irrevocably guaranteed on a subordinated basis by ARYZTA AG.

Zurich / Switzerland, 14 November 2014

ARYZTA AG (ARYZTA) announces the pricing of ?250 million Hybrid Securities to be
issued on 21 November 2014 by its Irish incorporated financing vehicle, ARYZTA
Euro Finance Limited. The Hybrid Securities will be unconditionally and
irrevocably guaranteed on a subordinated basis by ARYZTA. The proceeds from the
issue will be used for general corporate purposes outside of Switzerland.

The Hybrid Securities offer investors a coupon of 4.5% and are undated with a
first call date of 28 March 2019. The new Hybrid Securities will be placed with
institutional investors across Europe, with the transaction jointly managed by
BNP PARIBAS, JP Morgan and Rabobank. The Hybrid Securities will be listed on the
Irish Stock Exchange. The ISIN will be XS1134780557.

About ARYZTA
ARYZTA AG ('ARYZTA') is a global food business with a leadership position in
speciality bakery. ARYZTA is based in Zurich, Switzerland, with operations in
North America, South America, Europe, Asia, Australia and New Zealand. ARYZTA
has a primary listing on the SIX Swiss Exchange and a secondary listing on the
ISE Irish Exchange (SIX: ARYN, ISE: YZA).
ARYZTA is the majority shareholder (68.1%) in Origin Enterprises plc, which has
a listing on the AIM in London and the ESM in Dublin (AIM: OGN, ESM: OIZ).
Enquiries:
Paul Meade
Communications Officer




ARYZTA AG
Tel: +41 (0) 44 583 42 00
info(at)aryzta.com





This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: ARYZTA AG via GlobeNewswire
[HUG#1871629]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  aap: 110% LOQTEQ® sales growth in Q3/2014 underscores claim to become a leading European trauma company Sanofi : Genzyme's Lemtrada Approved by the FDA
Bereitgestellt von Benutzer: hugin
Datum: 14.11.2014 - 18:00 Uhr
Sprache: Deutsch
News-ID 352808
Anzahl Zeichen: 2659

contact information:
Town:

Zurich



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 292 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Announcement by ARYZTA AG"
steht unter der journalistisch-redaktionellen Verantwortung von

ARYZTA AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von ARYZTA AG



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z